2023 Q1 Form 10-K Financial Statement

#000149315223007486 Filed on March 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $436.3K $3.135M $2.251M
YoY Change -80.61% 13.26% 162.98%
% of Gross Profit
Research & Development $36.12K $77.92K $396.5K
YoY Change -90.89% -73.7% 1222.65%
% of Gross Profit
Depreciation & Amortization $168.8K $6.700K $3.530K
YoY Change 4680.74% 59.9% 35.77%
% of Gross Profit
Operating Expenses $472.5K $3.266M $2.760M
YoY Change -82.88% 5.54% 209.83%
Operating Profit -$2.822M -$2.760M
YoY Change 2.25%
Interest Expense -$1.879M -$1.561M -$64.51K
YoY Change 2812.87% 22725.44% -1152.37%
% of Operating Profit
Other Income/Expense, Net $2.981M $2.074M -$457.0K
YoY Change -752.2% 456.01%
Pretax Income -$1.720M -$2.753M -$3.281M
YoY Change -47.58% 0.91% 270.93%
Income Tax
% Of Pretax Income
Net Earnings -$1.700M -$2.753M -$3.281M
YoY Change -48.19% 0.91% 270.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.07 -$0.22
Diluted Earnings Per Share -$0.07 -$0.14 -$215.6K
COMMON SHARES
Basic Shares Outstanding 18.16M shares 15.71M shares 15.22M shares
Diluted Shares Outstanding 474.6K shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.732M $2.269M $4.378M
YoY Change -37.6% -70.81% 495.02%
Cash & Equivalents $2.732M $2.269M $4.378M
Short-Term Investments
Other Short-Term Assets $520.5K $598.3K $483.6K
YoY Change 7.63% 93.61% 114.95%
Inventory
Prepaid Expenses $383.6K $436.5K
Receivables $26.32K $48.94K $22.61K
Other Receivables $26.32K $48.94K $0.00
Total Short-Term Assets $3.279M $2.917M $4.884M
YoY Change -32.87% -64.07% 404.98%
LONG-TERM ASSETS
Property, Plant & Equipment $115.0K $121.7K $3.982M
YoY Change -97.11% 196.97% 87.37%
Goodwill
YoY Change
Intangibles $12.94M $13.09M
YoY Change 786.07%
Long-Term Investments
YoY Change
Other Assets $0.00 $2.086M $0.00
YoY Change 4021.64% -100.0%
Total Long-Term Assets $16.60M $18.93M $5.481M
YoY Change 202.92% 418.82% 108.71%
TOTAL ASSETS
Total Short-Term Assets $3.279M $2.917M $4.884M
Total Long-Term Assets $16.60M $18.93M $5.481M
Total Assets $19.88M $21.85M $10.37M
YoY Change 91.81% 85.69% 188.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $125.6K $498.2K $275.4K
YoY Change -54.4% -76.21%
Accrued Expenses $298.0K $365.5K $544.5K
YoY Change -45.27% -46.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.267M $3.942M
YoY Change
Total Short-Term Liabilities $5.353M $5.361M $1.761M
YoY Change 204.02% 134.5% -29.13%
LONG-TERM LIABILITIES
Long-Term Debt $44.34K $44.30K $48.02K
YoY Change -7.66% -6.4% 50.96%
Other Long-Term Liabilities $6.275M $5.899M $3.506M
YoY Change 78.96% 311.98% 1214.42%
Total Long-Term Liabilities $6.320M $5.943M $3.555M
YoY Change 77.79% 301.79% 1090.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.353M $5.361M $1.761M
Total Long-Term Liabilities $6.320M $5.943M $3.555M
Total Liabilities $11.67M $11.30M $5.315M
YoY Change 119.6% 200.22% 91.0%
SHAREHOLDERS EQUITY
Retained Earnings -$34.49M -$32.80M
YoY Change 64.82%
Common Stock $31.28M $27.14M
YoY Change 5.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.209M $10.54M $5.050M
YoY Change
Total Liabilities & Shareholders Equity $19.88M $21.85M $10.37M
YoY Change 91.81% 85.69% 188.46%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.700M -$2.753M -$3.281M
YoY Change -48.19% 0.91% 270.93%
Depreciation, Depletion And Amortization $168.8K $6.700K $3.530K
YoY Change 4680.74% 59.9% 35.77%
Cash From Operating Activities -$2.600M -$3.191M -$2.871M
YoY Change -9.43% 50.56% 671.72%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$38.27K -$500.0K
YoY Change -100.0% 400.26% 23048.15%
Acquisitions
YoY Change
Other Investing Activities -$55.03K
YoY Change 358.58%
Cash From Investing Activities -$16.75K -$500.0K
YoY Change -14.76% 23048.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.108M -2.260M
YoY Change -24876.54%
NET CHANGE
Cash From Operating Activities -$2.600M -3.191M -2.871M
Cash From Investing Activities -16.75K -500.0K
Cash From Financing Activities $3.108M -2.260M
Net Change In Cash $462.7K -5.467M $0.00
YoY Change 156.68% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$2.600M -$3.191M -$2.871M
Capital Expenditures $0.00 -$38.27K -$500.0K
Free Cash Flow -$2.600M -$3.153M -$2.371M
YoY Change 9.67% 49.29% 541.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 AGRI Write Off Of Deposit
WriteOffOfDeposit
usd
CY2022 AGRI Issuance Cost Related To Warrants
IssuanceCostRelatedToWarrants
usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021 AGRI Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2022 AGRI Increase Decrease In Lease Deposit
IncreaseDecreaseInLeaseDeposit
usd
CY2022 AGRI Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
usd
CY2021 us-gaap Proceeds From Deposits On Real Estate Sales
ProceedsFromDepositsOnRealEstateSales
usd
CY2022 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
usd
CY2021 AGRI Proceeds From Repayments Of Debentures Net Of Issuance Costs
ProceedsFromRepaymentsOfDebenturesNetOfIssuanceCosts
usd
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
CY2021 AGRI Payment For Acquisition Of Intangible Asset
PaymentForAcquisitionOfIntangibleAsset
usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 AGRI Write Off Of Deposit
WriteOffOfDeposit
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001826397
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q4 AGRI Lease Deposit Non Current
LeaseDepositNonCurrent
usd
CY2021Q4 AGRI Land Deposit Assets
LandDepositAssets
usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2021Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022Q4 AGRI Obligation To Issue Shares
ObligationToIssueShares
usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
usd
CY2022 AGRI Issuance Cost Related To Warrants
IssuanceCostRelatedToWarrants
usd
CY2022 AGRI Loss On Extension Of Debt Term
LossOnExtensionOfDebtTerm
usd
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2021 AGRI Shares Issued On Cashless Exercise Of Options
SharesIssuedOnCashlessExerciseOfOptions
usd
CY2021 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
usd
CY2022 AGRI Gain Loss On Extension Of Debt Term
GainLossOnExtensionOfDebtTerm
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
usd
CY2022Q2 dei Entity Public Float
EntityPublicFloat
28755938 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 AGRI Initial Fair Value Of Warrants Issued In Connection With Issuance Of Debentures
InitialFairValueOfWarrantsIssuedInConnectionWithIssuanceOfDebentures
usd
CY2021 AGRI Initial Fair Value Of Conversion Feature Of Debentures
InitialFairValueOfConversionFeatureOfDebentures
usd
CY2021 AGRI Prefunded Warrants Issued Related To Intangible Assets
PrefundedWarrantsIssuedRelatedToIntangibleAssets
usd
CY2021 AGRI Prefunded Warrants Issued Related To Land Deposit
PrefundedWarrantsIssuedRelatedToLandDeposit
usd
CY2021 AGRI Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
usd
CY2021 AGRI Initial Operating Lease Liability
InitialOperatingLeaseLiability
usd
CY2021 AGRI Initial Lease Rightofuse Asset
InitialLeaseRightofuseAsset
usd
CY2022 AGRI Initial Fair Value Of Warrants Liability
InitialFairValueOfWarrantsLiability
usd
CY2022 AGRI Preferred Stock Dividend Paid In Common Shares
PreferredStockDividendPaidInCommonShares
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 AGRI Unpaid Amount Related To Intangible Assets
UnpaidAmountRelatedToIntangibleAssets
usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2021 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2021 AGRI License Agreement
LicenseAgreement
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40578
CY2022 dei Entity Registrant Name
EntityRegistrantName
AGRIFORCE GROWING SYSTEMS LTD.
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
300 – 2233 Columbia Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V5Y 0M6
CY2022 dei City Area Code
CityAreaCode
(604)
CY2022 dei Local Phone Number
LocalPhoneNumber
757-0952
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18156154 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
27142762 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
25637543 usd
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
Costa Mesa, CA
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2269320 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7775290 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
48941 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
32326 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
598342 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
309040 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2916603 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8116656 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121672 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40971 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13089377 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1477237 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1540748 usd
CY2021Q4 AGRI Lease Deposit Non Current
LeaseDepositNonCurrent
50608 usd
CY2022Q4 AGRI Construction In Progress
ConstructionInProgress
2092533 usd
CY2021Q4 AGRI Construction In Progress
ConstructionInProgress
2079914 usd
CY2022Q4 AGRI Land Deposit Assets
LandDepositAssets
2085960 usd
CY2022Q4 us-gaap Assets
Assets
21846893 usd
CY2021Q4 us-gaap Assets
Assets
11765386 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1147739 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1532312 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
753727 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
3941916 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
271110 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5360765 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2286039 usd
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
12954 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1250060 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4649115 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1418964 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
44300 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
47326 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11304240 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3765283 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15795798 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15795798 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15176698 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16816695 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2203343 usd
CY2021Q4 AGRI Obligation To Issue Shares
ObligationToIssueShares
93295 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15176698 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32774094 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19900992 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-642710 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33086 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10542653 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8000103 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13482726 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21846893 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11765386 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3923329 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1766491 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
2669022 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
882146 usd
CY2022 AGRI Consulting
Consulting
2561908 usd
CY2021 AGRI Consulting
Consulting
1088413 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1327739 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
780135 usd
CY2022 AGRI Investor And Public Relations
InvestorAndPublicRelations
907436 usd
CY2021 AGRI Investor And Public Relations
InvestorAndPublicRelations
748349 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
615693 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
474338 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
420715 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
796141 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
387130 usd
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
318962 usd
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
168315 usd
CY2022 AGRI Travel And Entertainment
TravelAndEntertainment
280838 usd
CY2021 AGRI Travel And Entertainment
TravelAndEntertainment
69598 usd
CY2022 AGRI Shareholder And Regulatory
ShareholderAndRegulatory
221083 usd
CY2021 AGRI Shareholder And Regulatory
ShareholderAndRegulatory
143095 usd
CY2022 us-gaap Depreciation
Depreciation
22413 usd
CY2021 us-gaap Depreciation
Depreciation
11797 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-13656268 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-6928818 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
290079 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
162976 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
93973 usd
CY2022 AGRI Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
3719869 usd
CY2021 AGRI Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1191383 usd
CY2022 AGRI Accretion Interest On Debentures
AccretionInterestOnDebentures
3396578 usd
CY2021 AGRI Accretion Interest On Debentures
AccretionInterestOnDebentures
483529 usd
CY2021 AGRI Write Off Of Deposit
WriteOffOfDeposit
151711 usd
CY2021 AGRI Issuance Cost Related To Warrants
IssuanceCostRelatedToWarrants
374465 usd
CY2021 AGRI Loss On Extension Of Debt Term
LossOnExtensionOfDebtTerm
58952 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
75823 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12873102 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6643116 usd
CY2021 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
735932 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12873102 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7379048 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-609624 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-152140 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7531188 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
23353 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18080318 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11164311 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1403484 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13262712 usd
CY2021 AGRI Shares Issued On Exercise Of Warrants
SharesIssuedOnExerciseOfWarrants
283444 usd
CY2021 AGRI Shares Issued On Cashless Exercise Of Warrants
SharesIssuedOnCashlessExerciseOfWarrants
64992 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9123 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
648449 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
380073 usd
CY2021 AGRI Share Issued For Settlement Of Accrued Directors Fee
ShareIssuedForSettlementOfAccruedDirectorsFee
46783 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-2099842 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
796141 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6643116 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-152140 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8000103 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8000103 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
131532 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
520230 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
760162 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14192637 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
420715 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12873102 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-609624 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10542653 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
10542653 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12873102 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6643116 usd
CY2022 us-gaap Depreciation
Depreciation
22413 usd
CY2021 us-gaap Depreciation
Depreciation
11797 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
420715 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
796141 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
760162 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
321121 usd
CY2022 AGRI Shares Issued For Compensation And Bonus
SharesIssuedForCompensationAndBonus
520230 usd
CY2021 AGRI Shares Issued For Compensation And Bonus
SharesIssuedForCompensationAndBonus
134383 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3057825 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
483529 usd
CY2021 AGRI Gain Loss On Extension Of Debt Term
GainLossOnExtensionOfDebtTerm
58952 usd
CY2021 AGRI Write Off Of Deposit
WriteOffOfDeposit
151711 usd
CY2021 AGRI Issuance Cost Related To Warrants
IssuanceCostRelatedToWarrants
374465 usd
CY2022 AGRI Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
3719869 usd
CY2021 AGRI Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1191383 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
93973 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
16615 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
274302 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
235713 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
75552 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
662173 usd
CY2022 AGRI Increase Decrease In Rightofuse Asset
IncreaseDecreaseInRightofuseAsset
297034 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-255429 usd
CY2021 AGRI Increase Decrease In Lease Deposit
IncreaseDecreaseInLeaseDeposit
50608 usd
CY2021 AGRI Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
12954 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12079359 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5136947 usd
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
104986 usd
CY2021 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
25522 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
500000 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
225000 usd
CY2022 us-gaap Proceeds From Deposits On Real Estate Sales
ProceedsFromDepositsOnRealEstateSales
20000 usd
CY2021 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
12000 usd
CY2022 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
55028 usd
CY2021 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
744191 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-640014 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1006713 usd
CY2022 AGRI Proceeds From Repayments Of Debentures Net Of Issuance Costs
ProceedsFromRepaymentsOfDebenturesNetOfIssuanceCosts
12750000 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2805000 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1634894 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
69000 usd
CY2022 AGRI Payment For Acquisition Of Intangible Asset
PaymentForAcquisitionOfIntangibleAsset
750000 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
15639990 usd
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
2279374 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
238800 usd
CY2021 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
15932 usd
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
600000 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
750000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9123 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7560106 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13405471 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-346703 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-139931 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5505970 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7121880 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7775290 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
653410 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2269320 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7775290 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
338753 usd
CY2022 AGRI Initial Fair Value Of Warrants Issued In Connection With Issuance Of Debentures
InitialFairValueOfWarrantsIssuedInConnectionWithIssuanceOfDebentures
4080958 usd
CY2022 AGRI Initial Fair Value Of Conversion Feature Of Debentures
InitialFairValueOfConversionFeatureOfDebentures
3336535 usd
CY2022 AGRI Prefunded Warrants Issued Related To Intangible Assets
PrefundedWarrantsIssuedRelatedToIntangibleAssets
12106677 usd
CY2022 AGRI Prefunded Warrants Issued Related To Land Deposit
PrefundedWarrantsIssuedRelatedToLandDeposit
2085960 usd
CY2022 AGRI Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
131532 usd
CY2022 AGRI Initial Operating Lease Liability
InitialOperatingLeaseLiability
1776599 usd
CY2022 AGRI Initial Lease Rightofuse Asset
InitialLeaseRightofuseAsset
1837782 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28947 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.75
CY2021 AGRI Initial Fair Value Of Warrants Liability
InitialFairValueOfWarrantsLiability
374028 usd
CY2021 AGRI Preferred Stock Dividend Paid In Common Shares
PreferredStockDividendPaidInCommonShares
735932 usd
CY2021 us-gaap Stock Issued1
StockIssued1
6717873 usd
CY2021 AGRI Unpaid Amount Related To Intangible Assets
UnpaidAmountRelatedToIntangibleAssets
500000 usd
CY2022 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_806_eus-gaap--BasisOfAccounting_zDrQ6RDEEaNd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zSA8gIJ6OBJ7">BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principal of Consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements include the accounts of our wholly owned subsidiaries. We consolidate variable interest entities (VIEs) when we have variable interests and are the primary beneficiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All inter-company balances and transactions have been eliminated on consolidation. These consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries:</span></p> <p id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zhRDM5s80S2c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyovosdGeCyf" style="display: none">SCHEDULE OF CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of entity:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country of Incorporation</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Incorporation</span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_z6ovFuMtdpNj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zMj5GbfhzaM6" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEGrowingSystemsLtdMember_zsWJzxYNcIP" title="Date of Incorporation">Dec 22, 2017</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F4D_zRX6uOaGv0r3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd.*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___z8Vlh7OUXRol" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zbtqFQGTZPE" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaLtdMember_fKio___zNWfGwXctWB3" title="Date of Incorporation">Dec 4, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Holdings, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zWGJlyAMx0uc" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zv8bO25h2J4a" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Estate Holding and Development Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderHoldingsIncMember_zfP19SO43F03" title="Date of Incorporation">Sep 1, 2018</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Investments Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_zGuWFqx0WBL3" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8RzBB0UCUq3" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holding Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AgriFORCEInvestmentsIncMember_z8JNYUyFaMy9" title="Date of Incorporation">Apr 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Pender Management Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zw94cY8wnusj" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_z3E4UhP0eCXh" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management Advisory Services</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--WestPenderManagementCoMember_zaTh7GYJC9Q" title="Date of Incorporation">Jul 9, 2019</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGI IP Co.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zXmMq9fV1Al7" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_z3MpknKbzqv7" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--AGIIPCoMember_zShZjKDyLoKj" title="Date of Incorporation">Mar 5, 2020</span></span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--CountryOfIncorporation_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zLDvBZ4dJg71" style="font: 10pt Times New Roman, Times, Serif" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--Purpose_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zPRRoOAIZdJl" style="font: 10pt Times New Roman, Times, Serif" title="Purpose"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Food Product Manufacturing</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20220101__20221231__dei--LegalEntityAxis__custom--UnFoodCompanyCanadaMember_zX07CXmG3Q5" title="Date of Incorporation">June 20, 2022</span></span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0C_zZ4Xm9dcY2Yc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zcMukSJW7Qf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company Canada Ltd. changed its name from Daybreak AG Systems Ltd. on August 19, 2022. </span></td></tr> </table> <p id="xdx_8A8_ziAOir3N4PP4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">un(Think) Food Company, a wholly owned subsidiary commenced operations in 2022 and their results are consolidated into the results of the Company.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Functional and Reporting Currency</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”). Currency conversion to U.S. dollars is performed in accordance with ASC 830, Foreign Currency Matters.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">The preparation of our financial statements in accordance with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Significant estimates reflected in these financial statements include, but are not limited to, accounting for share-based compensation, valuation of derivative liabilities, valuation of embedded conversion feature, going concern, impairment as well as depreciation method. Actual results could differ from these estimates and those differences could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred substantial operating losses since its inception, and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As reflected in the financial statements, the Company had an accumulated deficit of approximately $<span id="xdx_90A_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20221231_zew2JyDi7Xeh" title="Accumulated deficit">32.8</span> million at December 31, 2022, a net loss of approximately $<span id="xdx_903_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20220101__20221231_ze2OImKFF9I9" title="Net loss">12.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, and approximately $<span id="xdx_908_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20220101__20221231_zd5utG6ZRat6" title="Net cash used in operating activities">12.1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of net cash used in operating activities for the year ended December 31, 2022. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company anticipates incurring additional losses until such time, if ever, that it can obtain marketing approval to sell, and then generate significant sales, of its technology that is currently in development. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is seeking additional financing to support its growth plans. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to currently outstanding common shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32800000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-12900000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12100000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021 AGRI Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled
94021 shares
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2022Q4 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P12M
CY2021 AGRI Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
6.70
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
717019 shares
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1776599 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1837782 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
12000 usd
CY2021Q4 us-gaap Deposit Assets
DepositAssets
32000 usd
CY2022Q4 AGRI Legal Retainer
LegalRetainer
24457 usd
CY2021Q4 AGRI Legal Retainer
LegalRetainer
33692 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
436496 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
214445 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
100337 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
25052 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
28903 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
598342 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
309040 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
163681 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62705 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42009 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21734 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121672 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40971 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22413 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11797 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.63
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M23D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
747060 shares
CY2022Q4 AGRI Construction In Progress
ConstructionInProgress
2092533 usd
CY2021Q4 AGRI Construction In Progress
ConstructionInProgress
2079914 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
498188 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
414117 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
365521 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
981027 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
284030 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
137168 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1147739 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1532312 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
500000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
509788 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.00
CY2021 AGRI Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P4Y5M19D
CY2022 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-12-31
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14025000 usd
CY2022Q4 AGRI Repayments And Conversions
RepaymentsAndConversions
-2955000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7128084 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
3941916 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
44300 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
60000 cad
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
47326 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
60000 cad
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1418964 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
7417493 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-63723 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-3719869 usd
CY2022 AGRI Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges
-403750 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4649115 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
420715 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
796141 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1382629 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
717019 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
414305 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
280938 shares
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
538358 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
634626 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1450918 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.01
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M17D
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1120719 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.23
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27 pure
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.14
CY2022 AGRI Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P4Y5M23D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25542 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.00
CY2022 AGRI Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelled
55908 shares
CY2022 AGRI Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
4.27
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1382629 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M26D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1382629 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M26D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
414305 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.23
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7805 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8000 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y25D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y3M21D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0335 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0092 pure
CY2022Q4 AGRI Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue
0.60
CY2021Q4 AGRI Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValue
2.59
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2546065 shares
CY2020Q4 AGRI Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
7.46
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
5770262 shares
CY2021Q4 AGRI Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
5.91
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
9876680 shares
CY2022Q4 AGRI Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
4.91
CY2022 AGRI Income Tax Expense Benefit Gross
IncomeTaxExpenseBenefitGross
-3023582 usd
CY2021 AGRI Income Tax Expense Benefit Gross
IncomeTaxExpenseBenefitGross
-1862697 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3023582 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17391927 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6487281 shares
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-11753662 usd
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-6202837 usd
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-1119440 usd
CY2021 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-440279 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12873102 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6643116 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12873102 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6643116 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2700 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2700 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3475738 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1793641 usd
CY2022 AGRI Income Tax Reconciliation Income Tax Expense Benefit At Change In Fair Valueof Derivative Liabilities
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities
-1032824 usd
CY2021 AGRI Income Tax Reconciliation Income Tax Expense Benefit At Change In Fair Valueof Derivative Liabilities
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtChangeInFairValueofDerivativeLiabilities
-321674 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
747719 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
484035 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
253556 usd
CY2022 AGRI Share Issue Costs
ShareIssueCosts
-108685 usd
CY2021 AGRI Share Issue Costs
ShareIssueCosts
-112812 usd
CY2022 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
298876 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
63035 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
111874 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1862697 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
7572932 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4459457 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
40962 usd
CY2022Q4 AGRI Deferred Tax Assets Share Issue Costs
DeferredTaxAssetsShareIssueCosts
130732 usd
CY2021Q4 AGRI Deferred Tax Assets Share Issue Costs
DeferredTaxAssetsShareIssueCosts
174377 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-5286 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7698378 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4674796 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7698378 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4674796 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2200000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
900000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
615693 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
474338 usd
CY2022 AGRI License Agreement
LicenseAgreement
256703 usd
CY2022 AGRI Product Development
ProductDevelopment
179563 usd
CY2021 AGRI Product Development
ProductDevelopment
296931 usd
CY2022 AGRI Design And Construction
DesignAndConstruction
179427 usd
CY2021 AGRI Design And Construction
DesignAndConstruction
177407 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
615693 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
474338 usd
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P7Y
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.070 pure
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
295601 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23361 usd
CY2022 us-gaap Lease Cost
LeaseCost
318962 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
271110 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
280409 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
296350 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
296350 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
296350 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
518613 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1959182 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
438012 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1521170 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
271110 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1250060 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6732000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4338000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
11070000 usd
CY2022 dei Auditor Firm
AuditorFirmId
688

Files In Submission

Name View Source Status
0001493152-23-007486-index-headers.html Edgar Link pending
0001493152-23-007486-index.html Edgar Link pending
0001493152-23-007486.txt Edgar Link pending
0001493152-23-007486-xbrl.zip Edgar Link pending
agri-20221231.xsd Edgar Link pending
ex14-1.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
agri-20221231_cal.xml Edgar Link unprocessable
agri-20221231_def.xml Edgar Link unprocessable
agri-20221231_lab.xml Edgar Link unprocessable
agri-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending